Cargando…

How to assess success of treatment when using multiple doses: the case of misoprostol for medical abortion

BACKGROUND: The assessment of treatment success in clinical trials when multiple (repeated) doses (courses) are involved is quite common, for example, in the case of infertility treatment with assisted reproductive technology (ART), and medical abortion using misoprostol alone or in combination with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seuc, Armando H., Shah, Iqbal H., Ali, Moazzam, Diaz-Olavarrieta, Claudia, Temmerman, Marleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637147/ https://www.ncbi.nlm.nih.gov/pubmed/26547301 http://dx.doi.org/10.1186/s13063-015-1035-0

Ejemplares similares

Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial
por: Olavarrieta, Claudia Diaz, et al.
Publicado: (2015)

Intermediate outcomes in randomized clinical trials: an introduction
por: Seuc, Armando H, et al.
Publicado: (2013)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Medication Abortion Safety and Effectiveness With Misoprostol Alone
por: Jayaweera, Ruvani, et al.
Publicado: (2023)

Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions
por: Szpot, Paweł, et al.
Publicado: (2022)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

In the name of public health: misoprostol and the new criminalization of abortion in Brazil
por: Assis, Mariana Prandini, et al.
Publicado: (2021)

Comparison of sublingual, vaginal, and oral misoprostol in cervical ripening for first trimester abortion
por: Parveen, Shagufta, et al.
Publicado: (2011)

Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies
por: Festin, Mario Philip R., et al.
Publicado: (2017)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

The effectiveness of using misoprostol with and without letrozole for successful medical abortion: A randomized placebo-controlled clinical trial
por: Naghshineh, Elham, et al.
Publicado: (2015)

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
por: Gupta, Anjali, et al.
Publicado: (2023)

Intravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
por: Haghighi, Ladan, et al.
Publicado: (2023)

Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics
por: Kerestes, Courtney, et al.
Publicado: (2019)

Misoprostol Abortion: Ultrasonography versus Beta-hCG Testing for Verification of Effectiveness
por: Behnamfar, Fariba, et al.
Publicado: (2013)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Health care providers’ perceptions of using misoprostol in the treatment of incomplete abortion in Malawi
por: Wagenheim, Cecilie Annette, et al.
Publicado: (2022)

Repeat Induced Abortion among Chinese Women Seeking Abortion: Two Cross Sectional Studies
por: Tang, Longmei, et al.
Publicado: (2021)

Why, when and how to update a meta-ethnography qualitative synthesis
por: France, Emma F., et al.
Publicado: (2016)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Fundamental discrepancies in abortion estimates and abortion-related mortality: A reevaluation of recent studies in Mexico with special reference to the International Classification of Diseases
por: Koch, Elard, et al.
Publicado: (2012)

Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis
por: Wu, Hang-lin, et al.
Publicado: (2017)

A Pill in the Lifeworld of Women in Burkina Faso: Can Misoprostol Reframe the Meaning of Abortion
por: Drabo, Seydou
Publicado: (2019)

Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill
por: Jayaweera, Ruvani T., et al.
Publicado: (2020)

Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy
por: Podolskyi, Volodymyr, et al.
Publicado: (2023)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Serum β-hCG concentration is a predictive factor for successful early medical abortion with vaginal misoprostol within 24 hours
por: Kim, Jung In, et al.
Publicado: (2017)

Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial
por: Young, David C., et al.
Publicado: (2020)

Comparison of the effect of vaginal misoprostol and evening primrose oil capsule with misoprostol alone on the consequences of abortion in women with intrauterine fetal death: a randomized clinical trial
por: Hashemi, Hadis, et al.
Publicado: (2023)

Development and pilot testing of the 2019 Canadian Abortion Provider Survey
por: Renner, Regina M., et al.
Publicado: (2023)

Experiences of Using Misoprostol in the Management of Incomplete Abortions: A Voice of Healthcare Workers in Central Malawi
por: Chakhame, Bertha Magreta, et al.
Publicado: (2022)

Sexual behaviour patterns and STI risk: results of a cluster analysis among men who have sex with men in Portugal
por: Blondeel, Karel, et al.
Publicado: (2021)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Misoprostol knowledge and distribution in Mexico City after the change in abortion law: a survey of pharmacy staff
por: Weaver, Greta, et al.
Publicado: (2020)

A Rare Type of Uterine Rupture Following Over-the-Counter Use of Misoprostol in Second Trimester Abortion
por: Jha, Nivedita, et al.
Publicado: (2021)

Harmonizing Methods for Estimating the Impact of Contraceptive Use on Unintended Pregnancy, Abortion, and Maternal Health
por: Askew, Ian, et al.
Publicado: (2017)

Exploring health care providers’ experiences of and perceptions towards the use of misoprostol for management of second trimester incomplete abortion in Central Uganda
por: Atuhairwe, Susan, et al.
Publicado: (2022)

In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments
por: Rehnström Loi, Ulrika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aji1hl0okl62bjsgj9uh2b290v